SLE treatment is highly individualized and depends on symptom manifestations, organ involvement, and disease severity.24,25 Duration of therapy is also highly individualized and is based on the patient's response. Antimalarials and nonsteroidal anti-inflammatory drugs (NSAIDs) are useful in the treatment of mild symptoms such as arthralgias and cutaneous manifestations. Oral corticosteroids and cytotoxic agents are used in more severe disease. Other medications (cyclophosphamide, immunosuppressive agents, tacrolimus) may be used depending on the severity and various organ systems involved. Belimumab is a newer agent that is approved for patients with mild to moderate disease currently taking standard therapy.29